Profound Medical Corp (PROF)
8.765
+0.56
(+6.76%)
USD |
NASDAQ |
May 15, 14:35
Profound Medical Profit Margin (Quarterly): -324.6% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -324.6% |
| December 31, 2023 | -443.5% |
| September 30, 2023 | -322.0% |
| June 30, 2023 | -459.1% |
| March 31, 2023 | -362.4% |
| December 31, 2022 | -757.9% |
| September 30, 2022 | -245.6% |
| June 30, 2022 | -292.8% |
| March 31, 2022 | -602.3% |
| December 31, 2021 | -1.02K% |
| September 30, 2021 | -236.3% |
| June 30, 2021 | -268.1% |
| March 31, 2021 | -1.05K% |
| December 31, 2020 | -261.4% |
| September 30, 2020 | -273.0% |
| Date | Value |
|---|---|
| June 30, 2020 | -516.9% |
| March 31, 2020 | -231.3% |
| December 31, 2019 | -182.9% |
| September 30, 2019 | -919.0% |
| June 30, 2019 | -1.02K% |
| March 31, 2019 | -198.3% |
| December 31, 2018 | -240.7% |
| September 30, 2018 | -1.69K% |
| June 30, 2018 | -2.73K% |
| March 31, 2018 | -1.31K% |
| December 31, 2017 | -234.3% |
| September 30, 2017 | -376.7% |
| June 30, 2017 | -486.7% |
| March 31, 2017 | -695.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.05K%
Minimum
Mar 2021
-182.9%
Maximum
Dec 2019
-489.5%
Average
-343.5%
Median
Profit Margin (Quarterly) Benchmarks
| Delcath Systems Inc | -2.07K% |
| Star Equity Holdings Inc | 12.25% |
| Exact Sciences Corp | -17.29% |
| CytoSorbents Corp | -70.73% |
| Progyny Inc | 6.08% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -67.15% |
| Return on Assets | -51.94% |
| Return on Invested Capital | -57.43% |
| Gross Profit Margin (Quarterly) | 66.44% |
| Operating Margin (Quarterly) | -391.7% |
| Return on Net Operating Assets | -51.94% |